An interventional study of CogFun RG occupational therapy in ADHD, sponsored by Hebrew University of Jerusalem. Recruiting at 1 site in Israel. Open to participants aged 18 Years to 60 Years. Per ClinicalTrials.gov, last updated 2024-10-15.
Sponsored by Hebrew University of Jerusalem · Not applicable, Interventional, and Supportive care
Among 85 studies in Attention Deficit Disorder with Hyperactivity with a site in Israel — 9 open to participants now, 10 under way, none of them phase 3. Attention Deficit Disorder with Hyperactivity · Israel.
Among the 85 studies in Attention Deficit Disorder with Hyperactivity with a site in Israel, this one is the 37th largest by planned enrollment of the 61 interventional ones that give a count, is one of 6 that started in 2024, is one of 38 with no phase, and was the 80th registered.
1,817 studies on the registry are indexed under Attention Deficit Disorder with Hyperactivity; 296 are open to participants now.
Browse Attention Deficit Disorder with Hyperactivity studies →9 of the 85 studies in Attention Deficit Disorder with Hyperactivity with a site in Israel are open now. Recruiting first, the newest first:
Adina Maeir · Sites in Israel
Ben-Gurion University of the Negev · Sites in Israel
Loewenstein Hospital · Sites in Israel
University of Haifa · Sites in Israel
Rabin Medical Center · Sites in Israel
A study can be open while its sites in Israel have not opened yet or have stopped. Only those recruiting at a site in Israel →
Of the 201 Attention Deficit Disorder with Hyperactivity studies recruiting now, 27 (13%) set no upper age limit and 169 (84%) stop at 75 or younger; 141 take children under 18; 55 take healthy volunteers.
This study: 18 Years to 60 Years · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
85 studies; the count open now beside each. This study's row is marked.
A study in two phases is counted once above. Listed by phase, each with its combined phases: Phase 1 6 · Phase 2 13 · Phase 3 4 · Phase 4 4
First in 2000; this study’s year is marked. 6 started in 2024.
By drug class, each counting the studies that test any of its medicines:
This study's planned enrollment of 40 is below the median of 71 across 1,437 interventional studies indexed under Attention Deficit Disorder with Hyperactivity.
Median enrollment 46 across the 61 interventional studies, 60 across the 23 observational. Of the 45 that completed or were terminated, 7 (16%) have results posted.
This tab as a report to print or save as PDF → With an account.
18 of 85 have an industry lead sponsor. The 10 most frequent:
Hebrew University of Jerusalem is the lead sponsor of 31 studies on the registry; 4 are open to participants now.
Hebrew University of Jerusalem has 2 studies filed under Attention Deficit Disorder with Hyperactivity — fewer than ten, so there is no comparison to draw.
1 of the studies in Attention Deficit Disorder with Hyperactivity with a site in Israel that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT07105475Ben-Gurion University of the NegevTreatment of ADHD Using High and Low Frequency Paired Associative Deep Transcranial Magnetic Stimulation | 2027-09-01 |
Among the 85 studies in Attention Deficit Disorder with Hyperactivity with a site in Israel, from their registry updates:
Nothing recorded among them since 2026-09-25.
This tab as a report to print or save as PDF → With an account.
The goal of this clinical trial is to examine the effectiveness of Cognitive-Functional Remote Group intervention (Cog-Fun RG).
The main questions of this study are 1. will participants demonstrate improvements in their executive functioning and quality of life after receiving the intervention, compared to waitlist controls. In addition, the investigators will examine if the waitlist group will demonstrate similar gains in these outcomes after receiving the same intervention.
the investigators will compare between the intervention group to the waiting list group to examine the effect of the intervention.
The participants will be allocated into two groups: an intervention group and a waiting list group.
The intervention group will receive the the Cog-Fun RG intervention, which includes 21 weekly group sessions, each lasting 90 minutes. the participants will be required to complete questionnaires at several time points: pre-post the intervention, as well as three months, six months, and one year after the intervention.
The waiting list controls will be required to complete questionnaires at several time points: pre-post waiting period, and then after the intervention, as well as three months, six months, and one year after the intervention.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
* Self Reported ADHD diagnoses
Exclusion Criteria:
* Self Reported other major health condition that impedes daily functioning
Occupational Therapy Remote Group Intervention . 21 weekly, online group sessions (4-6 participants in each group), lasting 90 minutes. Sessions are structured, comprising opening, collaborative learning, and summary. Session topics include learning about ADHD as a biological disorder of executive functioning, understanding the impact of ADHD on daily life, discovering strategies for coping with ADHD through exploration of life experiences, and preparing for future self-management.
Behavioral: CogFun RG occupational therapy
Waiting list, no intervention. After waitlist period will receive the same intervention as the first arm
21 weekly, online group sessions (4-6 participants in each group), lasting 90 minutes. Sessions are structured, comprising opening, collaborative learning, and summary. Session topics include learning about ADHD as a biological disorder of executive functioning, understanding the impact of ADHD on daily life, discovering strategies for coping with ADHD through exploration of life experiences, and preparing for future self management
The adult ADHD quality of life scale
Questionnaire with 29 questions relating to productivity, life outlook, relationships and psychological health. each question is rated on a 5 point scale. Raw scores are transformed to a 1-100 scale. higher scores indicate higher quality of life. The assessment will be conducted at baseline, immediately after the intervention, immediately after the waiting period and 3 months after the intervention follow up.
Time frame: at baseline, immediately after the intervention, immediately after the waiting period and 3 months after the intervention follow up
Behavioral Rating Inventory of Executive Functions (BRIEF) Adult Self -Report
Self-report questionnaire for adults evaluates Executive Functions (EF) in everyday contexts. Comprising 75 items rated on a three-point scale (1 = never, 2 = occasionally, 3 = often), the questionnaire categorizes items into nine scales representing distinct EF domains, along with two primary indices. The first, the Behavioral Regulation Index (BRI), encompasses inhibition, shifting, emotional regulation, and behavioral monitoring. The second, the Metacognitive Index (MI), includes working memory, initiation, planning/organization, task monitoring, and organization of materials. These indices contribute to a composite summary score known as the Global Executive Composite (GEC). raw scores are transposed to T-scores based on norms. The assessment will be conducted pre-post the intervention. Higher scores indicating greater difficulty with EF; a score of 65 or above signifies clinical impairment.
Time frame: at baseline, immediately after the intervention, immediately after the waiting period.
Plan to share: No — currently we do not have such a plan we will be happy to consider this in the future
Start is estimated for Nov 2024; primary completion for Oct 2025, 11 months later.
Of 479 non-industry interventional studies with no phase under Attention Deficit Disorder with Hyperactivity, half reached primary completion within 24 months of starting (the median), counting those still running; a quarter within 11 and three quarters within 43. This study's planned 11 months is below that.
Counting every sponsor, half of 510 studies reached it within 23 months; a quarter within 11 and three quarters within 41.
How these figures are worked out, and which studies are left out of them.
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Attention Deficit Disorder with Hyperactivity →
Hebrew University of Jerusalem